Literature DB >> 35794469

Selective attachment of a microtubule interacting peptide to plasmid DNA via a triplex forming oligonucleotide for transfection improvement.

Caroline Girardin1, Delphine Maze1, Cristine Gonçalves1, Yann Thierry Le Guen2, Kevin Pluchon2, Chantal Pichon1, Tristan Montier3,4, Patrick Midoux5.   

Abstract

In nonviral gene therapy approaches, the linkage of signal molecules to plasmid DNA (pDNA) is of interest for guiding its delivery to the nucleus. Here, we report its linkage to a peptide (P79-98) mediating migration on microtubules by using a triplex-forming oligonucleotide (TFO). pDNA of 5 kbp and 21 kbp containing 6 and 36 oligopurine • oligopyrimidine sites (TH), respectively, inserted outside the luciferase gene sequence were used. TFO with a dibenzocyclooctyl (DBCO) group in 3' end comprising some Bridged Nucleic Acid bases was conjugated by click chemistry with the peptide carrying an azide function in the C-terminal end. We found the formation of 6 and 18 triplex with pDNA of 5 kbp and 21 kbp, respectively. A twofold increase of the transfection efficiency was observed in the hind-limbs upon Hydrodynamic Limb Vein (HLV) injection in mice of naked P79-98 -pDNA of 21 kbp. This work paves the way for the selective equipping of pDNA with intracellular targeting molecules while preserving the full expression of the encoded gene.
© 2022. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Year:  2022        PMID: 35794469     DOI: 10.1038/s41434-022-00354-1

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  41 in total

1.  High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA.

Authors:  G Zhang; V Budker; J A Wolff
Journal:  Hum Gene Ther       Date:  1999-07-01       Impact factor: 5.695

Review 2.  Nonviral approach for targeted nucleic acid delivery.

Authors:  M Jafari; M Soltani; S Naahidi; D N Karunaratne; P Chen
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

Review 3.  Gene transfer by pulsed electric field is highly promising in cutaneous wound healing.

Authors:  Laure Gibot; Marie-Pierre Rols
Journal:  Expert Opin Biol Ther       Date:  2015-10-29       Impact factor: 4.388

Review 4.  Electrotransfer into skeletal muscle for protein expression.

Authors:  C Trollet; C Bloquel; D Scherman; P Bigey
Journal:  Curr Gene Ther       Date:  2006-10       Impact factor: 4.391

Review 5.  Genetic immunization with plasmid DNA mediated by electrotransfer.

Authors:  Alice Rochard; Daniel Scherman; Pascal Bigey
Journal:  Hum Gene Ther       Date:  2011-07       Impact factor: 5.695

Review 6.  Electric field-responsive nanoparticles and electric fields: physical, chemical, biological mechanisms and therapeutic prospects.

Authors:  Jelena Kolosnjaj-Tabi; Laure Gibot; Isabelle Fourquaux; Muriel Golzio; Marie-Pierre Rols
Journal:  Adv Drug Deliv Rev       Date:  2018-11-07       Impact factor: 15.470

Review 7.  Ultrasound and microbubble-assisted gene delivery: recent advances and ongoing challenges.

Authors:  Anthony Delalande; Michiel Postema; Nathalie Mignet; Patrick Midoux; Chantal Pichon
Journal:  Ther Deliv       Date:  2012-10

Review 8.  Recent progress in gene therapy to deliver nucleic acids with multivalent cationic vectors.

Authors:  Elena Junquera; Emilio Aicart
Journal:  Adv Colloid Interface Sci       Date:  2015-07-26       Impact factor: 12.984

Review 9.  A review of the tortuous path of nonviral gene delivery and recent progress.

Authors:  Divya Sharma; Sanjay Arora; Jagdish Singh; Buddhadev Layek
Journal:  Int J Biol Macromol       Date:  2021-06-01       Impact factor: 8.025

10.  Pre-clinical investigation of the synergy effect of interleukin-12 gene-electro-transfer during partially irreversible electropermeabilization against melanoma.

Authors:  Lise Pasquet; Elisabeth Bellard; Sophie Chabot; Bostjan Markelc; Marie-Pierre Rols; Justin Teissie; Muriel Golzio
Journal:  J Immunother Cancer       Date:  2019-06-26       Impact factor: 13.751

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.